In a recent study, researchers examined whether different exercise intensities could reduce symptoms of anxiety and depression in individuals with anxiety disorders.
Attention-deficit/hyperactivity disorder is the childhood mental health condition for which pharmacotherapy is best understood. But stimulants “fail” to assist many patients with ADHD, and this presents a clinical challenge.
In this Q&A, Sat Bir S. Khalsa, PhD, answered our questions about his team’s study that evaluated the efficacy of yoga vs cognitive behavioral therapy vs stress education for the treatment of generalized anxiety disorder.
Welcome to our latest slideshow! Click through the slides to learn about different presentations and causes of altered mental status. Each slide links to the full case report for more details.
Multifactorial Anxiety Disorder and Severe Compulsions Showing Decreased Frequency With Cannabis Treatment
The patient is a 30-year-old woman with a 10-year history of episodic severe anxiety that is characterized by aggressive self-induced vomiting and that cannot be redirected.
Stanislav Spivak, MD, Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University and Medical Director of the Johns Hopkins Psychiatric Mobile Treatment program discusses the findings of a recent study on barriers to the increased use of telemedicine in the mental health field.
Consultant360 spoke with Dr Kirsch, whose recent study found that individuals with autism spectrum disorder (ASD) may have an increased risk of comorbid depression, bipolar disorder, and anxiety compared with those without ASD.
Diane Simmons, PsyD, from Rutgers University, discusses unique challenges college students face in seeking appropriate psychological treatment, and innovative steps that universities like Rutgers have taken to improve the accessibility of these services.
In this commentary, Hani Raoul Khouzam MD, MPH, FAPA, lists the 7 pearls of wisdom that he learned about the identification and treatment of veterans with PTSD while working at the Department of Veteran Affairs for 26 years.
In a recent analysis, researchers investigated the relationship between opioid agonist treatment and all-cause and cause-specific mortality in patients with opioid dependence.